Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta‐Analysis
ABSTRACT Background Increasing remnant liver volume before major liver resection is an effective measure to reduce postoperative adverse events of hepatocellular carcinoma (HCC). We aimed to provide evidence for optimal management of HCC patients with insufficient future remnant liver volume (FRLV)....
Saved in:
| Main Authors: | Wenjie Li, Hang Li, Qingyan Kong, Fei Teng, Zheyu Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.71050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01) -
Transarterial chemoembolization in hepatocellular carcinoma treatment during the COVID-19 pandemic
by: Filipović Aleksandar, et al.
Published: (2024-01-01) -
Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01) -
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01) -
Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)